Christer Nordstedt

Christer Nordstedt

Director Ejecutivo en
Oblique Therapeutics AB
.
64 años
Health Technology
Commercial Services
Consumer Services

Perfil

Dr. Christer Nordstedt is a Chief Executive Officer at Oblique Therapeutics AB and a Chairman at Snevringe AB. He is on the Board of Directors at CINDA PHARMA AB. Dr. Nordstedt was previously employed as a Chief Executive Officer by Vivesto AB, a Chairman by Wntresearch AB, a Senior Vice President-Research & Development by Orion Oyj, a Senior Vice President by Eli Lilly Sweden AB, a Vice President by AstraZeneca AB, a Senior Vice President by Hoffman-LaRoche F & Co. AG, and a Global Research Manager by Teva GmbH.
He also served on the board at IRLAB Therapeutics AB, Fermion Ltd. and Orion Diagnostica AB. He received his doctorate degree from Karolinska Institutet.

Cargos activos de Christer Nordstedt

EmpresasCargoInicio
Snevringe AB
Presidente -
Director Ejecutivo 01/12/2022
Director/Miembro de la Junta -

Antiguos cargos conocidos de Christer Nordstedt.

EmpresasCargoFin
VIVESTO AB Director Ejecutivo 30/11/2022
ORION OYJ Director Técnico/Científico/I+D 05/03/2020
Fermion Ltd.
Director/Miembro de la Junta 01/01/2020
Orion Diagnostica AB
Director/Miembro de la Junta 01/01/2019
Corporate Officer/Principal 01/02/2017
Ver el detalle de la experiencia de Christer Nordstedt.

Formación de Christer Nordstedt.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

56

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Distribution Services

Orion Diagnostica AB

Fermion Ltd.

Health Technology

Health Technology

Snevringe AB

Commercial Services

  1. Bolsa de valores
  2. Insiders
  3. Christer Nordstedt